Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

ClinicalTrials.gov ID: NCT02010242

Public ClinicalTrials.gov record NCT02010242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria

Study identification

NCT ID
NCT02010242
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Calliditas Therapeutics AB
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

  • GKT137831 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2013
Primary completion
Jan 31, 2015
Completion
Feb 28, 2015
Last update posted
Feb 27, 2025

2013 – 2015

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Advanced Arizona Clinical Research Tucson Arizona 85712
The Endocrine Medical Group, Inc Orange California 92868
Clinical Research of South Florida Coral Gables Florida 33134
The Center for Diabetes and Endocrine Care Hollywood Florida 33021
Jacksonville Center for Clinical Research Jacksonville Florida 33216
Genoma Research Group, Inc. Miami Florida 33165
Coral Research Clinic Miami Florida 33175
Pines Clinical Research Inc. Pembroke Pines Florida 33028
Volunteer Medical Research Port Charlotte Florida 33952
John H. Stroger Jr. Hospital of Cook County Chicago Illinois 60612
Community Medical Research Partners Indianapolis Indiana 46234
Kansas City VA Medical Center Kansas City Missouri 64128
Creighton Diabetes Center Omaha Nebraska 68114
LLC DBA AccessMD Clinical Research Dayton Ohio 45424
Southeast Renal Research Institute Chattanooga Tennessee 37408
The University of Texas Southwestern Medical Center Dallas Texas 75201
17070 Red Oak dr Ste 103 Houston Texas 77090
Dialysis West University Health System San Antonio Texas 78229
McGuire VA Medical Center Richmond Virginia 23249
Zablocki VAMC Milwaukee Wisconsin 53095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02010242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02010242 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →